Biontech Se ADR
(BNTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,174,670 | 9,745,895 | 12,623,620 | 14,688,830 | 15,447,260 |
| Marketable Securities | 7,451,071 | 7,263,225 | 5,287,360 | 2,452,492 | 1,516,419 |
| Receivables | 304,332 | 2,077,053 | 2,526,954 | 2,493,851 | 3,259,751 |
| Inventories | 366,254 | 375,001 | 387,139 | 452,448 | 489,481 |
| Other current assets | 391,133 | 379,016 | 309,327 | 318,899 | 237,929 |
| TOTAL | $19,687,460 | $19,840,190 | $21,134,400 | $20,406,520 | $20,950,840 |
| Non-Current Assets | |||||
| PPE Net | 935,395 | 871,383 | 819,518 | 793,335 | 753,575 |
| Investments And Advances | 1,492,691 | 1,723,223 | 1,272,893 | 1,406,975 | 1,498,537 |
| Intangibles | 1,329,648 | 1,292,417 | 1,262,611 | 1,122,249 | 546,727 |
| Other Non-Current Assets | 502,805 | 436,994 | 410,300 | 441,237 | 485,119 |
| TOTAL | $4,260,540 | $4,324,017 | $3,765,322 | $3,763,796 | $3,283,958 |
| Total Assets | $23,947,990 | $24,164,210 | $24,899,720 | $24,170,320 | $24,234,790 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 38,015 | 33,982 | 30,413 | 43,536 | 42,089 |
| Accounts payable and accrued liabilities | 949,287 | 324,407 | 383,134 | 242,387 | 249,265 |
| Other current liabilities | 1,231,866 | 1,001,775 | 1,258,607 | 1,087,638 | 1,087,020 |
| TOTAL | $2,612,452 | $1,743,634 | $2,240,902 | $1,966,956 | $1,983,438 |
| Non-Current Liabilities | |||||
| Long Term Debt | 236,164 | 222,569 | 206,719 | 176,212 | 182,206 |
| Other Non-Current Liabilities | 519,712 | 475,754 | 496,992 | 357,213 | 358,196 |
| TOTAL | $796,583 | $741,099 | $746,679 | $580,335 | $545,309 |
| Total Liabilities | $3,409,035 | $2,484,733 | $2,987,581 | $2,547,291 | $2,528,747 |
| Shareholders' Equity | |||||
| Common Shares | 267,717 | 269,905 | 269,060 | 270,576 | 271,073 |
| Retained earnings | 20,073,850 | N/A | 21,389,820 | 21,012,000 | 20,875,490 |
| Other shareholders' equity | -1,117,671 | -1,027,565 | -1,065,320 | -984,537 | -983,679 |
| TOTAL | $20,538,960 | $21,679,470 | $21,912,140 | $21,623,030 | $21,706,050 |
| Total Liabilities And Equity | $23,947,995 | $24,164,203 | $24,899,721 | $24,170,321 | $24,234,797 |